Retrospective study on the tolerability using a four-cycle completion in elderly patients with extensive-stage small-cell lung cancer: a body mass index-based analysis

Key Points

• Decreased tolerability to anti-PD-L1 therapy correlates with low BMI in elderly patients.
• The study found that poor performance status independently affects tolerability outcomes.
• Analysis explored treatment responses and tolerability in elderly patients with extensive-stage small-cell lung cancer.
• Incorporating geriatric assessments may enhance treatment decisions and patient outcomes.

Abstract